Status:
COMPLETED
A Dose-Finding Study of MK0974 in Acute Migraine (MK0974-004)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Migraine
Eligibility:
All Genders
20-65 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to investigate the efficacy and safety of an MK 0974 for migraine headache and to identify an appropriate dose range for further study.
Eligibility Criteria
Inclusion
- Patient has at least 1 year history of migraine (with or without aura)
- Females of childbearing years must use acceptable contraception throughout trial
- Patient is in general good health based on screening assessment
Exclusion
- Patient is pregnant/breast-feeding (or is a female expecting to conceive during the study period)
- Patient has heart disease, uncontrolled hypertension (high blood pressure), uncontrolled diabetes or other significant disease
- Patient has major depression, other pain syndromes that might interfere with study assessments, psychiatric conditions, dementia, or significant neurological disorders (other then migraine)
- Patient has a history of gastric or small intestinal surgery or has a disease that causes malabsorption
- Patient has a history of cancer within the last 5 years
Key Trial Info
Start Date :
November 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2006
Estimated Enrollment :
420 Patients enrolled
Trial Details
Trial ID
NCT00246337
Start Date
November 1 2005
End Date
May 1 2006
Last Update
November 2 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.